Age-specific COVID-19 case-fatality rate: no evidence of changes over time.
作者信息
Signorelli Carlo, Odone Anna
机构信息
School of Medicine, University Vita-Salute San Raffaele, Via Olgettina 60, 20132, Milan, Italy.
出版信息
Int J Public Health. 2020 Nov;65(8):1435-1436. doi: 10.1007/s00038-020-01486-0. Epub 2020 Sep 25.
Abstract
摘要
相似文献
1
Age-specific COVID-19 case-fatality rate: no evidence of changes over time.特定年龄组的新冠肺炎病死率：无随时间变化的证据。
Int J Public Health. 2020 Nov;65(8):1435-1436. doi: 10.1007/s00038-020-01486-0. Epub 2020 Sep 25.
2
[Using Markov Chain Monte Carlo methods to estimate the age-specific case fatality rate of COVID-19].[使用马尔可夫链蒙特卡罗方法估计2019冠状病毒病的年龄特异性病死率]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Nov 10;41(11):1777-1781. doi: 10.3760/cma.j.cn112338-20200609-00823.
3
Monitoring trends and differences in COVID-19 case-fatality rates using decomposition methods: Contributions of age structure and age-specific fatality.使用分解方法监测 COVID-19 病死率的趋势和差异：年龄结构和特定年龄病死率的贡献。
PLoS One. 2020 Sep 10;15(9):e0238904. doi: 10.1371/journal.pone.0238904. eCollection 2020.
4
Increase in COVID-19 cases and case-fatality and case-recovery rates in Europe: A cross-temporal meta-analysis.欧洲 COVID-19 病例、病死率和治愈率的增加：一项跨时间的荟萃分析。
J Med Virol. 2020 Sep;92(9):1511-1517. doi: 10.1002/jmv.26035. Epub 2020 Jun 2.
5
Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019.及时对患者进行管理对降低 2019 年冠状病毒病死亡率的重要性。
J Infect Public Health. 2020 Jun;13(6):890-892. doi: 10.1016/j.jiph.2020.04.015. Epub 2020 May 11.
6
Data regarding country-specific variability in Covid-19 prevalence, incidence, and case fatality rate.关于新冠病毒感染率、发病率和病死率在不同国家之间差异的数据。
Data Brief. 2020 Sep 5;32:106276. doi: 10.1016/j.dib.2020.106276. eCollection 2020 Oct.
7
Coronavirus Disease 2019 (COVID-19): A Modeling Study of Factors Driving Variation in Case Fatality Rate by Country.2019 年冠状病毒病（COVID-19）：按国家划分的病死率变化驱动因素的建模研究。
Int J Environ Res Public Health. 2020 Nov 5;17(21):8189. doi: 10.3390/ijerph17218189.
8
Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States.估计美国有症状的 COVID-19 病例中的感染病死率。
Health Aff (Millwood). 2020 Jul;39(7):1229-1236. doi: 10.1377/hlthaff.2020.00455. Epub 2020 May 7.
9
[Preliminary analysis on COVID-19 case spectrum and spread intensity in different provinces in China except Hubei province].[中国除湖北省外不同省份新冠肺炎病例谱及传播强度的初步分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1601-1605. doi: 10.3760/cma.j.cn112338-20200314-00347.
10
Policy determinants of COVID-19 pandemic-induced fatality rates across nations.各国 COVID-19 大流行死亡率的政策决定因素。
Public Health. 2020 Oct;187:140-142. doi: 10.1016/j.puhe.2020.08.008. Epub 2020 Aug 18.
引用本文的文献
1
The effect of the COVID-19 pandemic on life expectancy in 27 countries.27 个国家 COVID-19 大流行对预期寿命的影响。
Sci Rep. 2023 Jun 1;13(1):8911. doi: 10.1038/s41598-023-35592-9.
2
Immunothrombosis and COVID-19 ‒ a nested post-hoc analysis from a 3186 patient cohort in a Latin American public reference hospital.免疫血栓形成与 COVID-19——拉丁美洲公立参考医院 3186 例患者队列的嵌套事后分析。
Clinics (Sao Paulo). 2023 Feb 28;78:100178. doi: 10.1016/j.clinsp.2023.100178. eCollection 2023.
3
COVID-19 orphans-Global patterns associated with the hidden pandemic.新冠疫情孤儿——与这一隐匿大流行相关的全球模式
PLOS Glob Public Health. 2022 Aug 31;2(8):e0000317. doi: 10.1371/journal.pgph.0000317. eCollection 2022.
4
Age discrimination, the right to life, and COVID-19 vaccination in countries with limited resources.资源有限国家中的年龄歧视、生命权与新冠病毒疫苗接种
J Soc Issues. 2022 Sep 30. doi: 10.1111/josi.12561.
5
Optimal vaccination strategies using a distributed model applied to COVID-19.使用分布式模型应用于新冠疫情的最优疫苗接种策略。
Cent Eur J Oper Res. 2023;31(2):499-521. doi: 10.1007/s10100-022-00819-z. Epub 2022 Sep 9.
6
Economic Inequality and COVID-19 Deaths and Cases in the First Wave: A Cross-Country Analysis.第一波疫情期间的经济不平等与新冠死亡病例及感染病例：一项跨国分析
Can Public Policy. 2021 Dec 1;47(4):537-553. doi: 10.3138/cpp.2021-033.
7
Seroprevalence of SARS-CoV-2 among Children Visiting a Tertiary Hospital during the Prevaccination Period, Southwest Region, Saudi Arabia.沙特阿拉伯西南部地区疫苗接种前时期前往三级医院就诊儿童中SARS-CoV-2的血清流行率
Vaccines (Basel). 2022 Aug 18;10(8):1344. doi: 10.3390/vaccines10081344.
8
Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections.新型冠状病毒2（SARS-CoV-2）的长期健康后果：基于严重急性呼吸综合征冠状病毒1（SARS-CoV-1）和中东呼吸综合征冠状病毒（MERS-CoV）感染的假设
Diagnostics (Basel). 2022 Jul 31;12(8):1852. doi: 10.3390/diagnostics12081852.
9
Modeling the change in European and US COVID-19 death rates.建模欧洲和美国 COVID-19 死亡率的变化。
PLoS One. 2022 Aug 17;17(8):e0268332. doi: 10.1371/journal.pone.0268332. eCollection 2022.
10
A real world analysis of COVID-19 impact on hospitalizations in older adults with chronic conditions from an Italian region.一项意大利地区的真实世界研究分析了 COVID-19 对患有慢性病的老年住院患者的影响。
Sci Rep. 2022 Aug 12;12(1):13704. doi: 10.1038/s41598-022-17941-2.
本文引用的文献
1
Planning for a second wave pandemic of COVID-19 and planning for winter : A statement from the Association of Schools of Public Health in the European Region.应对新冠疫情第二波大流行及冬季疫情的规划：欧洲区域公共卫生学院协会声明
Int J Public Health. 2020 Dec;65(9):1525-1527. doi: 10.1007/s00038-020-01455-7. Epub 2020 Aug 28.
2
COVID-19 mortality rate in nine high-income metropolitan regions.九个高收入大都市地区的新冠病毒疾病死亡率
Acta Biomed. 2020 Jul 20;91(9-S):7-18. doi: 10.23750/abm.v91i9-S.10134.
3
COVID-19 deaths in Lombardy, Italy: data in context.意大利伦巴第大区的新冠病毒疾病死亡病例：相关数据
Lancet Public Health. 2020 Jun;5(6):e310. doi: 10.1016/S2468-2667(20)30099-2. Epub 2020 Apr 25.
Zotero 插件